000 01450 a2200421 4500
005 20250517124350.0
264 0 _c20171121
008 201711s 0 0 eng d
022 _a2044-6055
024 7 _a10.1136/bmjopen-2016-012550
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhaliq, Waseem
245 0 0 _aPrevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study.
_h[electronic resource]
260 _bBMJ open
_c11 2016
300 _ae012550 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcademic Medical Centers
650 0 4 _aAge Distribution
650 0 4 _aAged
650 0 4 _aAnticarcinogenic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemoprevention
_xstatistics & numerical data
650 0 4 _aComorbidity
650 0 4 _aCross-Sectional Studies
650 0 4 _aFemale
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aMaryland
650 0 4 _aMiddle Aged
650 0 4 _aRisk Assessment
650 0 4 _aRisk Reduction Behavior
650 0 4 _aSeverity of Illness Index
650 0 4 _aSurveys and Questionnaires
700 1 _aJelovac, Danijela
700 1 _aWright, Scott M
773 0 _tBMJ open
_gvol. 6
_gno. 11
_gp. e012550
856 4 0 _uhttps://doi.org/10.1136/bmjopen-2016-012550
_zAvailable from publisher's website
999 _c26609559
_d26609559